Hallucinations, Auditory
9
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Testing a Peer-Support Group for Veterans Who Hear Voices
The ECHO Study: Compassion-focused Therapy for Young Voice Hearers and Their Caregivers
Role of Inferior Colliculi in Auditory Hallucinations
Improving Hallucinations by Targeting the rSTS With tES
Toward a Computationally-Informed, Personalized Treatment for Hallucinations
The Effectiveness of Combining AR/VR Technology in Virtual Clinical Auditory Hallucinations on the Comprehensive Auditory Hallucination Nursing Competency of Psychiatric Nurses
VR-based Avatar Therapy for Treatment of Auditory Hallucinations
fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations
Multi-dimensional Investigations of Negative Emotions and Drug-resistant Auditory Verbal Hallucinations in Psychosis